NUTX Earnings

NUTX reported its earnings on 2026-04-30, showcasing a revenue of 216.49M against an estimate of 227.80M, resulting in a -4.97% surprise. The EPS was 6.52, surpassing the expected 5.56 by 17.27%. The stock experienced a 17.09% price change on the earnings day and a 9.56% change over the next five days, reflecting market reactions to the results.

Following NUTX's earnings announcement on 2026-04-30, the stock price moved by 17.09% on the day of the release. Over the subsequent five days, it saw a 9.56% change. Historically, NUTX's stock price tends to shift by an average of -4.84% in the 10 days leading up to earnings and 16.7% in the 10 days following, providing insight into potential market.

For 2026/Q2, analysts estimate NUTX's annual revenue to reach 254.52M, while the EPS is projected at 3.85. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between NUTX's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, NUTX's stock price typically moves by -4.84% in the 10 days before its earnings and 16.7% in the 10 days after. For the upcoming 2026/Q2 earnings, analysts expect an EPS of 3.85 and revenue of 254.52M.

The earnings call summary presents a mixed picture. While there are positive elements such as revenue growth in Population Health and strategic expansion plans, concerns arise from decreased gross profit margins and unclear management responses in the Q&A. Additionally, arbitration costs and revenue per visit issues could impact investor sentiment. The absence of strong positive catalysts like new partnerships or record high revenue, combined with mixed financial metrics, suggests a neutral stock price movement in the near term.